Bausch Health
BHC
#3365
Rank
$3.37 B
Marketcap
$9.20
Share price
12.61%
Change (1 day)
34.90%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

P/S ratio for Bausch Health (BHC)

P/S ratio as of October 2024 (TTM): 0.3671

According to Bausch Health 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -14.9. At the end of 2024 the company had a P/S ratio of 0.2778.

P/S ratio history for Bausch Health from 2001 to 2023

PS ratio at the end of each year

Year P/S ratio Change
20240.2778-17.89%
20230.338420.49%
20220.2808-75.95%
20211.1727.41%
20200.9164-24.87%
20191.2257.59%
20180.7740-7.09%
20170.833060.51%
20160.5190-84.42%
20153.33-42.54%
20145.80-14.17%
20136.7632.2%
20125.11-12.42%
20115.84-19.4%
20107.24167.62%
20092.7137%
20081.97-23.21%
20072.57-19.58%
20063.20-20.91%
20054.0435.71%
20042.98-28.1%
20034.14-21.82%
20025.30-65.11%
200115.2

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
92.5 25,096.70%๐Ÿ‡บ๐Ÿ‡ธ USA
1.46 297.32%๐Ÿ‡บ๐Ÿ‡ธ USA